(Q35895858)

11 August 2017

1 reference

title

FEIBA: mode of action (English)

1 reference

11 August 2017

P L Turecek

1

1 reference

11 August 2017

K Váradi

series ordinal

2

1 reference

11 August 2017

H Gritsch

series ordinal

3

1 reference

11 August 2017

H P Schwarz

series ordinal

4

1 reference

11 August 2017

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

10 Suppl 2

1 reference

11 August 2017

page(s)

3-9

1 reference

Prothrombin complex concentrate

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Activated prothrombin complex concentrates: Approaches to their preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Factor VIII inhibitor bypassing activity: a suggested mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Monitoring the bioavailability of FEIBA with a thrombin generation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

The molecular basis of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Factor Xa and prothrombin: mechanism of action of FEIBA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

What is all that thrombin for?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00934.X

Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1021/BI972113+

Identifiers

DOI

10.1111/J.1365-2516.2004.00934.X

1 reference

11 August 2017

1 reference